Tagreed Alkaltham: Preventing the Risk of Transfusion Reactions Before They Occur
Tagreed Alkaltham, Transfusion Medicine Lab Supervisor at KSMC, shared a post on LinkedIn:
“Preventing Transfusion ReactionsÂ
How Do We Reduce the Risk Before It Happens?
Engineering Safety in Transfusion Medicine
After discussing recognition and post-transfusion work-up,
a more important question emerges:
How do we reduce the likelihood of a reaction before it ever happens?
In transfusion medicine, safety is not a response.
It is a system.
Prevention Begins Before Issue:
Risk reduction starts long before blood reaches the bedside:
- Accurate patient identification
- Proper antibody screening and history review
- Reviewing previous transfusion reactions
- Selecting special requirements when indicated (irradiated, etc.)
Many severe reactions are preventable at this stage.
Product Integrity Matters:
A strong system protects through:
- Proper storage and temperature monitoring
- Visual inspection before release
- Bacterial risk mitigation strategies
- Clear documentation and traceability
Safety is consistency, not luck.
The Bedside Is the Final Safety Layer:
- Independent identity verification
- Baseline vital signs
- Controlled initial infusion rate
- Early recognition of subtle symptoms
The first minutes matter, but they should not be the only defense.
Governance Makes Prevention Sustainable:
- Reaction audits
- Near-miss reporting
- Trend analysis
- Education feedback loops
Prevention is data-driven.
It is measured.
It is continuously refined.
Transfusion reactions are clinical events.
Prevention is a leadership decision.
Safety in transfusion medicine is not built in crisis
it is engineered long before the first drop flows”
Stay updated with Hemostasis Today.
-
Nov 9, 2026, 09:29Veronica Sanchez: A Framework for Woman’s Health
-
Nov 8, 2026, 19:31Anna Kajaste-Rudnitski: Presenting AAV-Induced p53 Signalling in Human CNS Cells at ESGCT 26
-
Nov 8, 2026, 19:29David McIntosh: Cybersecurity Matters, but Blood Availability Remains the Bigger Challenge
-
Nov 8, 2026, 19:26Wenxue Ma: An Integrative Framework for Macrophage-Mediated Therapeutic Resistance in Cancer
-
Nov 8, 2026, 19:25Yildiz Yigit: Presenting a Polycythemia Vera Case at the MPN Subcommittee Session
-
Nov 8, 2026, 18:56Denis Oduor: Strengthening the Regulation and Delivery of Blood Transfusion and Transplantation Services
-
Nov 8, 2026, 18:28Raghavendra Rao: A Narrative Review on Chronic Venous Disease during Pregnancy
-
Nov 8, 2026, 17:57Dhiren Patel: PLD1-Derived Phospholipids Regulate NAD Kinase and ROS Production in Neutrophils
-
Nov 8, 2026, 17:48Andra T.: What Causes Antiphospholipid Syndrome? – Four Steps, not One Cause